500 students get glimpse of health research
The initiative brought together students from eight schools across Dibrugarh, Assam and Khumlwng, Tripura, offering them hands-on exposure to biomedical research through interactive laboratory tours, research exhibitions, and live demonstrations of ongoing scientific projects.
"We want you to see that science isn't confined to textbooks. It's alive in our labs, in our fieldwork, and in the way we respond to the public health needs of our country," said Dr Suman Kanungo, director of ICMR-RMRCNE.
addressing the enthusiastic gathering of young learners.Dr Kanungo emphasised the crucial role of cultivating a scientific mindset and innovation among youth, highlighting how their involvement will be instrumental in shaping India's future as the nation progresses towards Viksit Bharat by 2047.
The comprehensive programme offered students a rare behind-the-scenes look at medical research through guided laboratory tours, research exhibitions, poster sessions, video presentations, science quizzes, and model demonstrations.
Students had the opportunity to observe ongoing scientific work firsthand and interact directly with ICMR scientists, gaining valuable insights into their research methodologies and discoveries.
To enhance the learning experience, organisers introduced "Dr Curio," a specially designed mascot that served as a friendly guide throughout the day. The mascot's presence helped create an engaging atmosphere, making complex scientific concepts more accessible and encouraging students to develop a meaningful connection with science.
A highlight of the event was the screening of four specially curated short films showcasing ICMR's landmark achievements. Students learned about the development of Covaxin, India's indigenous COVID-19 vaccine, the innovative iDRONE initiative for healthcare delivery in remote areas, India's ambitious tuberculosis elimination efforts, and Vishanu Yudh Abhyas, a nationwide mock drill designed to assess the country's pandemic preparedness capabilities.
The programme also featured presentations on ICMR-RMRCNE's research activities and a demonstration of the MyHeart mobile application, illustrating how technology is being leveraged to improve healthcare outcomes in the region.
The In'eract've activities provided students with hands-on learning experiences that went far beyond traditional classroom education. By observing real laboratory work and engaging with active researchers, participants gained a deeper understanding of how scientific inquiry translates into practical solutions for public health challenges.
The SHINE Initiative represents a significant step in ICMR's broader mission to nurture scientific curiosity among young minds while raising awareness about the critical role of research in enhancing public health outcomes across the Northeast region.
Stay updated with the latest local news from your
city
on
Times of India
(TOI). Check upcoming
bank holidays
,
public holidays
, and current
gold rates
and
silver prices
in your area.
Get the latest lifestyle updates on Times of India, along with
Raksha Bandhan wishes
,
messages
and
quotes
!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Nepal Verified for Rubella Elimination by WHO
Kathmandu: The World Health Organization (WHO) has announced that Nepal has eliminated rubella as a public health problem, marking a major milestone in the country's fight against vaccine-preventable diseases. Rubella, also known as German measles, is a highly contagious viral infection that can cause miscarriage, stillbirth, or severe birth defects if contracted during pregnancy. It is preventable through safe and cost-effective vaccines. The SEA-RVC, which met from 22–24 July 2025, reviewed surveillance data and immunization coverage submitted by Nepal's national verification committee before recommending verification of elimination. Nepal is now the sixth country in WHO's South-East Asia Region to achieve rubella elimination, joining Bhutan, DPR Korea, Maldives, Sri Lanka, and Timor-Leste. Nepal introduced the rubella-containing vaccine in 2012 through a nationwide campaign for children aged 9 months to 15 years, followed by the addition of a second dose to the routine immunization schedule in 2016. Four national campaigns—in 2012, 2016, 2020, and 2024—ensured wide coverage despite challenges such as the COVID-19 pandemic and major earthquakes in 2015 and 2023. By 2024, over 95% of children had received at least one dose of rubella vaccine. Key initiatives included 'immunization month' campaigns, outreach for missed children, and a district-level drive to achieve 'fully immunized' status. Nepal also became the first country in WHO South-East Asia to introduce a robust laboratory testing algorithm to strengthen surveillance. Health Minister Pradip Paudel said, 'Nepal's achievement of rubella elimination is yet another testament to the success of the national immunization program ahead of the regional target, which has long been one of the strongest pillars of our health care system. Gavi and WHO's steadfast support to the programme and the overall health sector in Nepal is deeply valued and acknowledged. I take this moment to thank and congratulate all the leaders, health workers, volunteers and community members who've contributed to this achievement. And I call upon all stakeholders to continue their unwavering support so that no child in Nepal has to suffer from a vaccine-preventable disease.' 'Congratulations to Nepal for eliminating rubella. This public health achievement is the result of close collaboration between the government, health workers, partners, and communities. WHO is proud to have contributed to this journey and remains committed to supporting Nepal to sustain this accomplishment,' said Dr. Rajesh Sambhajirao Pandav, WHO Representative to Nepal.
Time of India
3 hours ago
- Time of India
EkinCare elevates Somak Ray to co-founder from vice president of operations
Corporate health benefits platform ekincare has announced the elevation of Somak Ray from vice-president of operations to co-founder. In his new role, Ray will oversee the scaling of operations, development of strategic partnerships, and identification of new growth avenues in domestic and international markets. Since joining ekincare in 2016, Ray has played a foundational role in building the organisation's operational infrastructure and scaling its service delivery . His contributions include leading India's largest cashless Covid-19 vaccination initiative, expanding the company's cashless provider network to more than 50,000 partners nationwide, and launching new service lines that have diversified revenue streams and enhanced market presence. 'Somak's experience and consistency have played a big role in shaping our growth story so far,' said Kiran Kalakuntla , CEO and co-founder, ekincare. 'This elevation is just the beginning of an exciting new phase for him and for us. As we set our sights on expanding globally, I'm confident his leadership will help us scale faster, serve our customers better, and create lasting impact in the markets we enter.' "In this expanded role, my focus will be on advancing our mission globally, making preventive and primary healthcare more accessible, technology-enabled, and outcome- driven for enterprises and their employees," said Ray. The elevation reflects the firm's emphasis on strengthening its leadership core, reinforcing stakeholder confidence, and positioning itself for sustainable growth in new markets. Founded in 2014 by Kiran Kalakuntla, ekincare is headquartered in Hyderabad. The platform simplifies corporate wellness by combining advanced data analytics with services like telemedicine, e-pharmacy, mental health support, and comprehensive health check-ups. The platform serves over 1.5 million+ employees across 1000+ organisations including Fortune 500 companies like PepsiCo , BlackRock and Visa. Its investors include Ventureast, Eight Roads Ventures and Touchstone Equities.
NDTV
3 hours ago
- NDTV
Rubella Eliminated As A Public Health Issue In Nepal: Where India Stands
Nepal has reached a remarkable milestone: the World Health Organization (WHO) has officially declared that rubella has been eliminated as a public health problem in Nepal. This achievement reflects years of hard work and unwavering commitment. "Nepal's success reflects the unwavering commitment of its leadership, persistent efforts of the health care workers and volunteers, and unstinting support of engaged and informed communities," Dr Catharina Boehme, officer-in-charge of WHO's South-East Asia office, said while echoing the findings of the SEA-Regional Verification Commission (SEA-RVC). According to WHO's SEA-RVC, the achievement is a result of both strong immunization campaigns and reliable surveillance systems. What Is Rubella And Why Does It Matter? Rubella, also known as German measles, is a contagious viral infection that usually causes a mild fever and rash. While rubella may appear harmless in children and young adults, it poses a very serious risk to pregnant women. If a woman contracts rubella during early pregnancy, it can cause Congenital Rubella Syndrome (CRS) in the baby, leading to birth defects such as hearing impairment, cataracts, heart problems, and developmental delays. According to the WHO, rubella remains a leading cause of preventable congenital disabilities in many countries. This is why eliminating rubella is considered a major public health priority across the world. Nepal's Victory: A Landmark In Public Health Nepal's strategy for eliminating rubella was multi-pronged and persistent. The rubella vaccine was introduced in 2012, covering children between the ages of nine months and fifteen years. A second dose was added to the national immunization schedule in 2016 to strengthen immunity. To maintain momentum, Nepal conducted four nationwide vaccination campaigns in 2012, 2016, 2020, and 2024. These campaigns ensured that even children who were missed earlier got vaccinated, keeping coverage high despite challenges such as the COVID-19 pandemic and devastating earthquakes. By 2024, Nepal had achieved over 95% coverage for at least one dose of the rubella vaccine, a benchmark that the WHO considers essential for elimination. Alongside vaccines, Nepal also introduced innovative approaches such as dedicating an "immunisation month" every year, incentivising districts that achieved full coverage, and using community outreach to identify and vaccinate missed populations. Importantly, the country also developed one of the region's first robust laboratory testing algorithms for rubella, which helped strengthen disease surveillance and ensure that every suspected case was properly investigated. With this achievement, Nepal joins the ranks of Bhutan, DPR Korea, the Maldives, Sri Lanka, and Timor-Leste, the other countries in the WHO South-East Asia Region that have successfully eliminated rubella. Where Does India Stand? A Progress Report India has also made remarkable progress in reducing rubella cases, although the journey is still ongoing. Here's a detailed look at India's current efforts and challenges: National Immunization Framework Since 2017, India's Universal Immunization Programme (UIP) has included the Measles-Rubella (MR) vaccine. Under this programme, children receive two free doses: the first between 9-12 months, and the second between 16-24 months. This nationwide rollout was a huge step towards rubella elimination. Vaccination Coverage According to official data from 2024-25, India has achieved around 93.7% coverage for the first MR dose and 92.2% for the second dose. While this is close to WHO's recommended 95% benchmark, the remaining gap highlights the need for sustained campaigns, especially in remote and underserved areas. District-Level Achievements Between January and March 2025, 332 districts in India reported zero measles cases, while 487 districts reported zero rubella cases. This is an encouraging sign that elimination is within reach if coverage can be maintained consistently across all states. National Campaigns and Initiatives In 2025, the government launched the National Zero Measles-Rubella Elimination Campaign, with the ambitious aim of reaching every child left out of previous drives. The campaign includes multilingual awareness materials, digital outreach, and a strong "ACT NOW" policy to encourage parents and caregivers to get children vaccinated without delay. International Recognition India's progress has not gone unnoticed. In 2024, India received the Measles and Rubella Champion Award for demonstrating leadership and robust immunization strategies. This international recognition has reinforced India's role as a regional leader in public health. Mass Vaccination Drives Since 2017, India has vaccinated over 348 million children against measles and rubella. Recent campaigns between November 2022 and May 2023 reached millions more, especially in high-risk states and urban areas where outbreaks were more likely. Surveillance and Laboratory Strengthening India has expanded its surveillance systems, including a strong network of laboratories, to track suspected cases. Case-based monitoring of "fever with rash" illnesses helps health officials quickly identify and contain outbreaks. Support from WHO's National Public Health Support Network has played a big role in these improvements. State-Level Examples States like Kerala have shown strong leadership. In May 2025, Kerala conducted a two-week MR vaccination drive across selected districts, using mobile booths and community campaigns. This drive achieved 92% coverage for the first doseand 87% for the second dose, with a special focus on migrant workers and hard-to-reach communities. What Can The Public Do? While government campaigns and international support are crucial, public participation is equally important in eliminating rubella. Parents should ensure that children receive both recommended MR doses on time. Families must participate actively in immunization drives, help spread awareness, and encourage relatives and neighbours to get vaccinated. Adults can also play a role by reporting suspected cases of fever and rash to local health authorities, which helps strengthen surveillance. Nepal's success in eliminating rubella shows that strong leadership, community engagement, and consistent vaccination campaigns can indeed eradicate deadly viruses. India is very close to achieving the same milestone, but the final stretch requires unwavering commitment. With sustained immunization coverage, improved surveillance, and active public participation, India can eliminate rubella by 2026 and protect future generations from preventable suffering.
